To confirm that KIF20A regulates breast cancer stemness, we assessed the expression of canonical stem cell markers (Oct4, Sox2, or NANOG) and found that KIF20A siRNA transfection led to decreased mRNA levels of these markers in Hs578T cells (Figure 2C). The gene discussed is SOX2; the disease is breast cancer.